Atlas Trials

Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma

Clinical trial NCT00112736 · COMPLETED

Trial details

NCT number
NCT00112736
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Diffuse AstrocytomaAdult Giant Cell GlioblastomaAdult GlioblastomaAdult GliosarcomaAdult Mixed GliomaAdult Pilocytic AstrocytomaAdult Pineal Gland AstrocytomaAdult Subependymal Giant Cell AstrocytomaRecurrent Adult Brain Tumor
Start date
2005-04-01
Primary completion
2010-04-01
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.